This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Civitas Therapeutics, Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Rachel Ryznal: Innovator in Pulmonary Pharmaceutical Formulations
Introduction
Rachel Ryznal is a notable inventor based in North Oxford, MA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly those aimed at pulmonary delivery. Her innovative work focuses on improving the stability and effectiveness of therapeutic agents administered through the respiratory system.
Latest Patents
Rachel holds a patent for her invention titled "Pulmonary pharmaceutical formulations." This patent presents improved pharmaceutical formulations for pulmonary delivery that exhibit enhanced chemical and physical stability compared to existing formulations. The invention comprises a mass of biocompatible particles containing an active agent and a hydrogenated starch hydrosylate (HSH). The inclusion of HSH represents a significant advancement over prior art, providing a more effective method for treating various disease conditions through respiratory administration.
Career Highlights
Rachel is currently associated with Civitas Therapeutics, Inc., where she continues to develop innovative solutions in the pharmaceutical industry. Her work is characterized by a commitment to enhancing patient care through advanced drug delivery systems.
Collaborations
Rachel has collaborated with esteemed colleagues, including Charles D. Blizzard and Michael M. Lipp, who share her dedication to advancing pharmaceutical science.
Conclusion
Rachel Ryznal's contributions to pulmonary pharmaceutical formulations exemplify her innovative spirit and commitment to improving healthcare. Her work not only enhances the stability of therapeutic agents but also paves the way for more effective treatments for patients in need.